Pro- and antiapoptotic markers in upper tract urothelial carcinoma associated with Balkan endemic nephropathy

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1699-1711

  Jankovic Velickovic, Ljubinka ^a   Stojnev, Slavica ^a   Ristic Petrovic, Ana ^a   Dolicanin, Zana ^a   Hattori, Takanori ^b   Mukaisho, Kenichi ^b   Stojanovic, Mariola ^c   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF NI   (Serbia)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Public Health Institute   (Serbia)

Author keywords

apoptosis; Balkan endemic nephropathy; Bax; Bcl 2; Caspase 3; Fas; Survivin; upper tract urothelial carcinoma

Indexed keywords

CASPASE 3; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; BALKAN ENDEMIC NEPHROPATHY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; UPPER TRACT UROTHELIAL CARCINOMA;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BALKAN NEPHROPATHY; CASE-CONTROL STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS;

EID: 81455143977     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2011/752790     Document Type: Article

References (46)

1. Polenakovic M., Stefanovic V., Cameron J. S., Davison A. M., Grunfeld J. P., Kerr D., Ritz E., Balkan nephropathy. Oxford Textbook of Clinical Nephrology 1992 Oxford, UK Oxford University Press 857 866
2. Stefanovi V., Polenakovi M., Fifty years of research in balkan endemic nephropathy: where are we now? Nephron 2009 112 2 c51 c55
3. Toncheva D., Dimitrov T., Stojanova S., Etiology of Balkan endemic nephropathy: a multifactorial disease? European Journal of Epidemiology 1998 14 4 389 394 (Pubitemid 28288463)
4. Stefanovic V., Toncheva D., Atanasova S., Polenakovic M., Etiology of balkan endemic nephropathy and associated urothelial cancer American Journal of Nephrology 2006 26 1 1 11
5. Ivi M., Etiology of endemic nephropathy Lijecnicki Vjesnik 1969 91 12 1273 1281
6. Cosyns J. P., Jadoul M., Squifflet J. P., De Plaen J. F., Ferluga D., Van Ypersele De Strihou C., Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney International 1994 45 6 1680 1688 (Pubitemid 24207504)
7. Petkova-Bocharova T., Castegnaro M., Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria Food Additives and Contaminants 1985 2 4 267 270 (Pubitemid 16256411)
8. Feder G. L., Radovanovic Z., Finkelman R. B., Relationship between weathered coal deposits and the etiology of Balkan endemic nephropathy Kidney International Supplements 1991 40 34 S-9 S-11
9. Petkovic S. D., Epidemiology and treatment of renal pelvic and ureteral tumors Journal of Urology 1975 114 6 856 865
10. Stefanovic V., Radovanovic Z., Balkan endemic nephropathy and associated urothelial cancer Nature Clinical Practice Urology 2008 5 2 105 112 (Pubitemid 351248099)
11. Krasteva M. E., Georgieva E. I., Germline p53 single-base changes associated with Balkan endemic nephropathy Biochemical and Biophysical Research Communications 2006 342 2 562 567 (Pubitemid 43292339)
12. Grollman A. P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., Suzuki N., Fernandes A., Rosenquist T., Medverec Z., Jakovina K., Brdar B., Slade N., Turesky R. J., Goodenough A. K., Rieger R., Vukeli M., Jelakovi B., Aristolochic acid and the etiology of endemic (Balkan) nephropathy Proceedings of the National Academy of Sciences of the United States of America 2007 104 29 12129 12134 (Pubitemid 47185641)
13. Velickovic L. J., Hattori T., Stefanovic V., Molecular markers in upper urothelial carcinoma associated to Balkan endemic nephropathy. Aristolochic acid as the major risk factor of the worldwide disease TheScientificWorldJournal 2009 9 1360 1373
14. McKnight J. J., Gray S. B., O'Kane H. F., Johnston S. R., Williamson K. E., Apoptosis and chemotherapy for bladder cancer Journal of Urology 2005 173 3 683 690 (Pubitemid 40239320)
15. Karam J. A., Lotan Y., Karakiewicz P. I., Ashfaq R., Sagalowsky A. I., Roehrborn C. G., Shariat S. F., Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy Lancet Oncology 2007 8 2 128 136 (Pubitemid 46158371)
16. Lopez-Beltran A., Sauter G., Gasser T., Eble J. N., Sauter G., Epstein J. I., Sesterhenn I. A., Tumors of the urinary system. Infiltrating urothelial carcinoma World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs 2004 Lyon, France IARC 93 109
17. Sobin L. H., Wittekind C., TNM Classification of Malignant Tumors 2002 6th New York, NY, USA John Wiley Son
18. Genega E. M., Kapali M., Torres-Quinones M., Huang W. C., Knauss J. S., Wang L. P., Raghunath P. N., Kozlowski C., Malkowicz S. B., Tomaszewski J. E., Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney Modern Pathology 2005 18 1 11 18 (Pubitemid 40128089)
19. Giannopoulou I., Nakopoulou L., Zervas A., Lazaris A. C., Stravodimos C., Giannopoulos A., Davaris P. S., Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications Urological Research 2002 30 5 342 345 (Pubitemid 36056646)
20. Yin W., Chen N., Zhang Y., Zeng H., Chen X., He Y., Wang X., Zhou Q., Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder Modern Pathology 2006 19 11 1487 1497 (Pubitemid 44624169)
21. Singh R. P., Tyagi A., Sharma G., Mohan S., Agarwal R., Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin Clinical Cancer Research 2008 14 1 300 308 (Pubitemid 351378006)
22. Bressenot A., Marchal S., Bezdetnaya L., Garrier J., Guillemin F., Plénat F., Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma Journal of Histochemistry and Cytochemistry 2009 57 4 289 300
23. Colin P., Koenig P., Ouzzane A., Berthon N., Villers A., Biserte J., Rouprt M., Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract BJU International 2009 104 10 1436 1440
24. Catto J. W. F., Yates D. R., Rehman I., Azzouzi A. R., Patterson J., Sibony M., Cussenot O., Hamdy F. C., Behavior of urothelial carcinoma with respect to anatomical location Journal of Urology 2007 177 5 1715 1720 (Pubitemid 46560675)
25. Eltz S., Comperat E., Cussenot O., Rouprt M., Molecular and histological markers in urothelial carcinomas of the upper urinary tract BJU International 2008 102 5 532 535
26. Debelle F. D., Vanherweghem J. L., Nortier J. L., Aristolochic acid nephropathy: a worldwide problem Kidney International 2008 74 2 158 169 (Pubitemid 351915079)
27. Stefanovic V., Cukuranovic R., Miljkovic S., Marinkovic D., Toncheva D., Fifty years of balkan endemic nephropathy: challenges of study using epidemiological method Renal Failure 2009 31 5 409 418
28. Jankovic Velickovic L., Hattori T., Dolicanin Z., Visnjic M., Krstic M., Ilic I., Cukuranovic R., Rajic M., Stefanovic V., Upper urothelial carcinoma in Balkan endemic nephropathy and non-endemic regions: a comparative study of pathological features Pathology Research and Practice 2009 205 2 89 96
29. Velickovic L. J., Hattori T., Visnjic M., Dimov I., Stojanovic M., Stefanovic V., E-cadherin expression in upper urothelial carcinoma in Balkan Endemic Nephropathy and non-endemic regions Pathology Research and Practice 2009 205 10 682 689
30. Nouraee N., Mowla S. J., Ozhand A., Parvin M., Ziaee S. A. M., Hatefi N., Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker Urology Journal 2009 6 2 101 108
31. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., Tanigawa N., Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clinical Cancer Research 2000 6 1 127 134 (Pubitemid 30064984)
32. Moussa O., Abol-Enein H., Bissada N. K., Keane T., Ghoneim M. A., Watson D. K., Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer Journal of Urology 2006 175 6 2312 2316
33. Fields A. C., Cotsonis G., Sexton D., Santoianni R., Cohen C., Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome Modern Pathology 2004 17 11 1378 1385 (Pubitemid 39472993)
34. Shariat S. F., Ashfaq R., Karakiewicz P. I., Saeedi O., Sagalowsky A. I., Lotan Y., Survivin expression is associated with bladder cancer presence, stage, progression, and mortality Cancer 2007 109 6 1106 1113 (Pubitemid 46435389)
35. Skagias L., Politi E., Karameris A., Sambaziotis D., Archondakis A., Ntinis A., Moreas I., Vasou O., Koutselini H., Patsouris E., Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining Anticancer Research 2009 29 10 4163 4167
36. Jeong I. G., Kim S. H., Jeon H. G., Kim B. H., Moon K. C., Lee S. E., Lee E., Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract Human Pathology 2009 40 5 668 677
37. Nakanishi K., Tominaga S., Hiroi S., Kawai T., Aida S., Kasamatsu H., Aurues T., Hayashi T., Ikeda T., Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract Virchows Archiv 2002 441 6 559 563 (Pubitemid 35435825)
38. Chen Y. B., Tu J. J., Kao J., Zhou X. K., Chen Y. T., Survivin as a useful adjunct marker for the grading of papillary urothelial carcinoma Archives of Pathology and Laboratory Medicine 2008 132 2 224 231 (Pubitemid 351213791)
39. Kadhim H. S., Abdulamir A. S., Hafidh R. R., Abubaker F., Abbas K. A., Investigations in the molecular events of transitional cell carcinoma of the bladder American Journal of Biochemistry and Biotechnology 2008 4 4 408 415
40. Karamitopoulou E., Rentsch C. A., Markwalder R., Vallan C., Thalmann G. N., Brunner T., Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens Pathology 2010 42 1 37 42
41. Nakanishi K., Tominaga S., Kawai T., Torikata C., Aurues T., Ikeda T., Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract Virchows Archiv 1998 432 5 445 450 (Pubitemid 28266201)
42. Reed J. C., Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities Cell Death and Differentiation 2006 13 8 1378 1386 (Pubitemid 44057473)
43. Curtin J. F., Cotter T. G., Live and let die: regulatory mechanisms in Fas-mediated apoptosis Cellular Signalling 2003 15 11 983 992 (Pubitemid 37130156)
44. Yamana K., Bilim V., Hara N., Kasahara T., Itoi T., Maruyama R., Nishiyama T., Takahashi K., Tomita Y., Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression British Journal of Cancer 2005 93 5 544 551 (Pubitemid 43079997)
45. Gown A. M., Willingham M. C., Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3 Journal of Histochemistry and Cytochemistry 2002 50 4 449 454 (Pubitemid 34250583)
46. Oudejans J. J., Harijadi A., Cillessen S. A. G. M., Busson P., Tan I. B., Dukers D. F., Vos W., Hariwiyanto B., Middeldorp J., Meijer C. J. L. M., Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome Modern Pathology 2005 18 7 877 885 (Pubitemid 41059946)